Board of directors and company secretary
Sir David McMurtry
Chairman and Chief Executive
Sir David McMurtry, CBE, RDI, FREng, FRS, CEng, FIMechE, Chairman and Chief Executive, was employed by Rolls-Royce plc, Bristol, for 17 years, latterly holding the positions of Deputy Chief Designer and Assistant Chief of Engine Design for all Rolls-Royce engines manufactured at Filton, Bristol. After inventing the original probe in the early 1970s, Sir David co-founded Renishaw in 1973 with John Deer.
His CBE was awarded “for services to Science and Technology” and he was appointed a Royal Designer for Industry (“RDI”) in 1989. He is a visiting professor of Huddersfield University and has been awarded an honorary Doctorate of Engineering at the University of Birmingham and honorary degrees of Doctor of Engineering at Heriot-Watt University, the University of Bristol and the University of Bath. He has also been awarded an honorary fellowship at Cardiff University. Sir David is a Chartered Engineer, a Fellow of the Institution of Mechanical Engineers, a Fellow of the American Society of Manufacturing Engineers, a Fellow of the Royal Academy of Engineering, and in 2011 became a Fellow of The Royal Society. The Institute of Physics jointly awarded its 2012 Swan Medal to Sir David and John Deer for their role in founding Renishaw and leading it to become one of the world's principal manufacturers of metrology equipment. In addition to his role as Chairman and Chief Executive, Sir David also has responsibility for Group technology and is the Chair of the Nomination Committee.
John Deer, Deputy Chairman, trained as a mechanical engineer and worked for Rolls-Royce plc, Bristol, from 1960 to 1974. He was Managing Director of Renishaw from 1974 to 1989, primarily involved in the commercial direction of the Group, with particular emphasis on marketing and the establishment of the Group's wholly-owned subsidiaries in the USA, Ireland, Japan, Germany, France and Italy. John and Sir David McMurtry were members of the four-man team of Renishaw engineers honoured with the MacRobert Award in 1987. In 2012 John was awarded the Swan Medal by the Institute of Physics jointly with Sir David McMurtry for their role in founding Renishaw and leading it to become one of the world's principal manufacturers of metrology equipment. In September 2014 John was awarded an honorary fellowship at the University of South Wales for his contribution to UK manufacturing. In October 2014 John and Sir David were jointly honoured with a Lifetime Achievement Award at Gloucestershire Business Awards. John is responsible for Group manufacturing and Group quality.
Group Finance Director and Company Secretary
Allen Roberts, FCA, Group Finance Director, qualified as a Chartered Accountant in 1972 and is a Fellow of the Institute of Chartered Accountants in England and Wales. Before joining Renishaw in 1979, he was employed for 11 years by Peat, Marwick, Mitchell & Co. He was appointed a director of Renishaw plc in 1980. Allen heads Group finance, business systems, human resources and Wotton Travel Ltd. He is also responsible for the metrology regulatory and quality assurance functions. Allen reports to the Board on corporate social responsibility matters.
Group Engineering Director
Geoff McFarland, Group Engineering Director, has a degree in computer aided mechanical engineering from Heriot-Watt University, where he subsequently worked for several years as a research associate. He is a visiting professor at the University of Bath and an honorary professor at Heriot-Watt University. After working in the medical device and electronic manufacturing sectors, Geoff joined Renishaw's research facility in Edinburgh in 1994, before moving to the headquarters to become Director and General Manager of the CMM products line. Geoff was appointed to the Board of Renishaw plc in July 2002. He heads the Group engineering function and is also responsible for Group IP and patents, and the neurological product line.
Group Sales and Marketing Director
William joined Renishaw in 1997 and became Director and General Manager for the laser and calibration products line in 2007. He holds a degree in physics from Oxford University and an MBA from Bath University. In 2014 William subsequently became Director and General Manager of the machine tool products line. In December 2015 William was appointed to the new role of Director of Group Sales and Marketing and became a member of the Executive Board. He was appointed to the Board of Renishaw plc in August 2016. William is responsible for Group sales and marketing and is chair of the overseas marketing subsidiaries.
Sir David Grant
Senior Independent Director
Sir David Grant, CBE, FREng, FLSW, CEng, FIET was Vice-Chancellor of Cardiff University from October 2001 until August 2012, with responsibility for 30,000 students, 6,000 members of staff, and an annual income of £430m. Prior to that he held leadership positions at a number of international engineering companies including Dowty Group and GEC plc where he was Group Technical Director. Sir David is currently Senior Independent Director of IQE plc, non-executive director of the Defence Science and Technology Laboratory, and chair of the National Physical Laboratory (NPL). He was a Vice-President of the Royal Academy of Engineering from 2007 to 2012. Sir David received a knighthood in the Queen's Birthday Honours 2016 for his contributions to engineering, technology and education. He was appointed to the board of Renishaw plc in April 2012. Sir David is a member of the Nomination, Audit and Remuneration committees.
John Jeans, CBE CEng, is currently Chair of Edinburgh Molecular Imaging and Imanova (an imaging research partnership between three London Universities and the MRC). He is also a non-executive director of ProMetic Life Sciences Inc., ProMetic Pharmaceuticals Small Molecule Therapeutics Ltd and chair of the Strategic Advisory Board for the Singapore Government's Diagnostics Hub. John leads Innovate UK's Stratified Medicine Advisory Board and the KTN's Health Board. He serves on several government bodies including the Ministerial Committee on Medical Technologies. Previously he was the Deputy Chief Executive of the Medical Research Council, chair of Cardiff University, chair of UK Biocentre Ltd and a director of the University Employers Association. John has held senior international leadership positions in global companies including Smith & Nephew, Bristol Myers Squibb, Johnson & Johnson and Amersham plc (now GE Healthcare). He headed the commercial function of GE's Life Science business and was Chair of its UK Healthcare Company.
John holds experience ranging from medical devices and therapeutic pharmaceuticals to in-vivo and in-vitro diagnostics, encompassing research, product development, manufacturing and commercialisation. In June 2014 John was appointed advisor to the Prime Minister at the Office of Life Sciences for the medical technology sector. He was awarded the CBE for services to Life Sciences, Healthcare and Science in 2012. Appointed to the Board of Renishaw plc in April 2013, John is a member of the Audit, Remuneration and Nomination committees.
Carol Chesney, FCA, non-executive director, is a Chartered Accountant who worked at Arthur Andersen in audit services for seven years. Carol worked for some time in the group accounts function at English China Clays plc before joining Halma plc, where she is now Company Secretary, having also been Group Financial Controller. Carol's role at Halma includes corporate governance, legal compliance, risk and insurance, equity incentives, pensions, management of internal audit, property, health and safety compliance, environmental reporting and anti-bribery and corruption compliance. Carol was appointed a director of Renishaw plc in October 2012. She is Chair of the Audit Committee, and a member of the Remuneration and Nomination committees.
Kath Durrant is currently Group HR Director for Ferguson plc (formerly known as Wolseley plc) and a member of its Executive Committee. She was previously Group HR Director at Rolls-Royce plc and prior to that held a variety of senior positions at AstraZeneca plc, including Vice President, HR and Communications for its research and development division. Before joining AstraZeneca, Kath spent a short time at GUS plc and eleven years at GlaxoSmithKline plc. Appointed as a non-executive director of Renishaw plc in January 2015, Kath is a member of the Nomination committee and chair of the Remuneration committee.